Link: University of Iowa

Alumnus Michael Feldkamp et al. received top honors at Vanderbilt’s TechVenture Challange

Biochemistry Alumnus Michael Feldkamp (Shea Lab, 2010 PhD) and a team of of graduate, business and law students from Vanderbilt University won top honors at last week’s TechVenture Challenge which teaches students how to bring patented “inventions” by Vanderbilt faculty members to market.

Mike’s team, named First Diagnostics, pitched Corafix (fluorocoxib A), a fluorescently labeled selective inhibitor of the COX-2 enzyme developed by Md. Jashim Uddin, Ph.D., Research Assistant Professor of Biochemistry and scientific mentor of First Diagnostics team, and Lawrence Marnett, Ph.D., Associate Vice Chancellor for Research and Director of the Vanderbilt Institute of Chemical Biology. COX-2 is overexpressed in many cancers, including colorectal cancer.

Read more about competition and their winning proposal here.

Leave a Reply

You must be logged in to post a comment.